U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07502417) titled 'A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants' on March 26.
Brief Summary: The objective of this study is to assess the effect of repeated doses of ABBV-722 on the single dose pharmacokinetics (PK) of ethinyl estradiol and levonorgestrel.
Study Start Date: March 25
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: Ethinyl Estradiol + Levonorgestrel
Oral
DRUG: ABBV-722
Oral
Recruitment Status: RECRUITING
Sponsor: AbbVie
Published by HT Digital Content Services with permission from Health Daily Digest....